Longitudinal cohort study identifies circulating microRNAs for disease classification and treatment response in pediatric epilepsy, suggesting biomarkers for precision care.
Circulating miRNAs represent promising, minimally invasive biomarkers in pediatric epilepsy. miR-146a-5p may aid etiologic classification, whereas miR-15a-5p and miR-106b-5p could serve as dynamic indicators of disease burden and treatment response, supporting biomarker-driven precision approaches in epilepsy care.
No takes yet. Share an insight, caveat, or question.
Salimbene et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: